Related Experiment Video
Updated: Feb 14, 2026

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Published on: April 13, 2021
Viral Infections in Kidney Transplant Recipients: Current Practice and Updates
Kayinsola Kehinde Babatunde1, Donnchadh Reidy1, Dearbhail Ni Cathain1
1Department of Nephrology, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland.
Abstract:
Kidney transplantation is considered the gold standard treatment for patients with end-stage kidney disease. Historically, outcomes in kidney transplantation have been focused on reducing rates of rejection as the dominant cause of graft loss. However, managing the risk of rejection with infection continues to be a delicate balancing act for transplant physicians. It has long been recognised that viruses are an important cause of morbidity and mortality in immunosuppressed patients with significant implications for kidney graft function and patient outcomes worldwide. This is a review article with literature selected from the PubMed database using relevant terms related to kidney transplantation and infectious diseases. This article focuses on the key viruses affecting kidney transplant recipients, including cytomegalovirus, polyoma virus, Epstein-Barr virus, varicella zoster virus, adenovirus, hepatitis B and C, and new emerging viruses. It examines differing epidemiology, diagnostic challenges, screening methods, and antiviral treatments. Key challenges for the international nephrology community include increased global mobility resulting in rapid shifts in viral epidemiology, increasing antimicrobial resistance, virus-associated malignancies, and suboptimal assays for screening donors and transplant recipients.
Insights
Viral infections pose significant risks to kidney transplant recipients, impacting graft function and survival. This review highlights key viruses, challenges in diagnosis and treatment, and the need for improved screening strategies.
Area of Science:
- Nephrology
- Infectious Diseases
- Transplantation Immunology
Background:
- Kidney transplantation is the optimal treatment for end-stage kidney disease.
- Historically, focus was on rejection, but viral infections are now major causes of morbidity and mortality in immunosuppressed patients.
- Viruses significantly impact kidney graft function and patient outcomes globally.
Purpose of the Study:
- To review the epidemiology, diagnostics, screening, and treatment of key viruses affecting kidney transplant recipients.
- To discuss challenges including shifting viral epidemiology, antimicrobial resistance, and virus-associated malignancies.
- To highlight the need for improved screening assays for donors and recipients.
Main Methods:
- Literature review of articles from the PubMed database.
- Search terms included kidney transplantation and infectious diseases.
- Focus on viruses such as cytomegalovirus, polyoma virus, Epstein-Barr virus, and others.
Main Results:
- Identified key viruses impacting kidney transplant recipients and their implications.
- Examined differences in viral epidemiology, diagnostic challenges, and available treatments.
- Highlighted emerging viral threats and the complexities of managing viral infections.
Conclusions:
- Viral infections are a critical concern in kidney transplant recipients, necessitating careful management.
- International collaboration is needed to address challenges like global mobility's impact on viral epidemiology and antimicrobial resistance.
- Development of superior screening methods for donors and recipients is essential for better outcomes.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Viral Recombination
Kidney Structure
Viral Structure

